MLS-101
Mineralys Therapeutics
[]
$mlys new article : mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.